DUBLIN--(BUSINESS WIRE)--The "Infectious Respiratory Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product, By Sample Type, By Application, By Technology, By End-Use, By Region, Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global infectious respiratory disease diagnostic market size is expected to reach USD 43.74 billion by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
The increasing prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products have increased the market's demand. The rising concern about the disease in low-economic countries and the development of cost-practical tools for diagnosing infectious diseases offers many opportunities to drive the market's growth.
The rising Covid-19 infections across the globe is major factor boosting the demand for diagnosis. For instance, in April 2020, 6.08 million people across globe were infected with COVID-19 diseases, which increased the need for rapid diagnostics testing is likely to boost the infectious respiratory disease diagnostic market.
Pneumonia affects around 4.2 million people every year, according to the UN. Various key players are developing innovative techniques for improving production meeting the growing demand in diagnostics and consumables. Furthermore, companies are advancing their diagnosis products by introducing new techniques for target-specific and accurate results.
Infectious Respiratory Disease Diagnostics Market Report Highlights
- Due to high testing rates for the diagnosis of COVID-19 and the commercialization of multiple assays in recent years, consumables account for the largest market.
- Based on the application, Covid-19 segment attributed for the largest market share due to the high incidence rate, increasing product approvals, and high R&D initiatives for launching innovative products.
- The increased requirements of RT-PCR tests for diagnosing COVID-19, RSV, influenza, and others have witnessed growth for the molecular diagnostic segment over the forecast period.
- Many laboratories are entering into strategic initiatives with multiple organizations to offer COVID-19 testing to combat the rising incidence of the disease driving the growth of the diagnostic laboratories segment.
- North America anticipated the largest market share due to the increased penetration of IVD products, a rising disposable income, and a high prevalence of tuberculosis in underdeveloped countries.
- The global market is highly competitive owing to the existence of large industry players with global presence Abbott, BD, bioMerieux SA, Bio-Rad Laboratories, Inc., Danaher, F. Hoffmann-La Roche Ltd., Koninklijke Philips N.V., Qiagen, Quidel Corporation, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc.
The publisher has segmented the infectious respiratory disease diagnostics market report based on, technology, product, application, work-flow, end-use, and regions:
Infectious Respiratory Disease Diagnostics, Product Type Outlook (Revenue - USD Billion, 2018 - 2030)
- Instruments
- Imaging Tests
- Respiratory Measurement Devices
- Other
- Consumables
- Services
Infectious Respiratory Disease Diagnostics, Sample Type Outlook (Revenue - USD Billion, 2018 - 2030)
- Saliva
- Nasopharyngeal Swabs
- Anterior Nasal Region
- Blood
- Others
Infectious Respiratory Disease Diagnostics, Application Outlook (Revenue - USD Billion, 2018 - 2030)
- Covid-19
- Influenza
- Respiratory Syncytial Virus
- Tuberculosis
- Streptococcus Testing
- Other Respiratory Disease Testing
Infectious Respiratory Disease Diagnostics, Technology Outlook (Revenue - USD Billion, 2018 - 2030)
- Immunoassay
- Molecular Diagnostic
- Microbiology
- Other Technologies
Infectious Respiratory Disease Diagnostics, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)
- Hospitals
- Diagnostic Laboratories
- Physician Offices
- Others
Infectious Respiratory Disease Diagnostics, Regional Outlook (Revenue - USD Billion, 2018 - 2030)
- North America
- U.S
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Market Dynamics
Drivers and Opportunities
- Rising R&D Investments In Respiratory Disease Testing
- High Prevalence Of Infectious Respiratory Diseases Globally
Restraints and Challenges
- High Prices Of Diagnostic Products
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Research Methodology
4. Global Infectious Respiratory Disease Diagnostics Market Insights
5. Global Infectious Respiratory Disease Diagnostics Market, by Product
6. Global Infectious Respiratory Disease Diagnostics Market, by Sample Type
7. Global Infectious Respiratory Disease Diagnostics Market, by Application
8. Global Infectious Respiratory Disease Diagnostics Market, by Technology
9. Global Infectious Respiratory Disease Diagnostics Market, by End-Use
10. Global Infectious Respiratory Disease Diagnostics Market, by Geography
11. Competitive Landscape
12. Company Profiles
Companies Mentioned
- Abbott
- BD
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Danaher
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V.
- Qiagen
- Quidel Corporation
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
For more information about this report visit https://www.researchandmarkets.com/r/30ylfv
